Treatment of choice for severe falciparum malaria is:
**Core Concept**
Severe falciparum malaria is a life-threatening complication of Plasmodium falciparum infection, requiring prompt and effective treatment to prevent mortality. The treatment of choice should target the parasite's life cycle, particularly the asexual erythrocytic stage, and also address potential complications such as cerebral edema and acidosis.
**Why the Correct Answer is Right**
Artemisinin-based combination therapies (ACTs) are the current recommended treatment for severe falciparum malaria. These combinations typically pair an artemisinin derivative (e.g., artesunate) with a longer-acting antimalarial (e.g., mefloquine or lumefantrine). Artemisinin derivatives quickly reduce parasite load, while the companion antimalarial component helps prevent recrudescence. This combination approach minimizes the risk of resistance development and improves patient outcomes. The World Health Organization (WHO) and other global health authorities recommend ACTs as the first-line treatment for severe falciparum malaria.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify the use of artemisinin-based combination therapy, which is the current standard of care for severe falciparum malaria.
**Option B:** This option is incorrect as chloroquine is no longer recommended for the treatment of falciparum malaria due to widespread resistance.
**Option C:** This option is incorrect as doxycycline is not a recommended treatment for severe falciparum malaria, especially in areas with high resistance.
**Clinical Pearl / High-Yield Fact**
In areas with high resistance, artemisinin-based combination therapies should be used according to the local treatment guidelines, and patients should be closely monitored for potential side effects and complications.
**Correct Answer:** C. Artemisinin-based combination therapy (ACT).